Rare diseases
Investigational molecules
Locations
Back to France3 344 clinical trials in Le Chesnay-Rocquencourt, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on the Effects of TCP-25 Gel for Wound Healing in Patients with Epidermolysis Bullosa
FranceStudy on the Effectiveness of Etoposide, Carboplatin, and Cisplatin in Patients with Localized Digestive Neuroendocrine Carcinomas
FranceStudy on Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa Using Skin Grafts with Genetically Corrected Autologous Keratinocytes and Fibroblasts
FranceA study of ruxolitinib as first treatment for children with haemophagocytic lymphohistiocytosis (HLH)
FranceStudy on Stopping Dupilumab in Patients with Severe Asthma Who Have Been on the Drug for Over 3 Years
FranceStudy on Colchicine and Aspirin for Improving Heart Health in Adults with Type 2 Diabetes Without Previous Heart Events
FranceStudy on How Well Etavopivat Works for Adolescents and Adults with Sickle Cell Disease
FranceStudy on Pembrolizumab for Patients with Early Triple-Negative Breast Cancer Responding Well to Initial Treatment
FranceStudy on the Effectiveness of Cemiplimab, Carboplatin, and Paclitaxel for Unfit or Elderly Patients with Unresectable Stage III Non-Small Cell Lung Cancer
FranceStudy on the Effectiveness of Oxybutynin for Children with Overactive Neurogenic Bladder Due to Spina Bifida
FranceStudy on Dapagliflozin for Heart and Kidney Health in Adults After ICU Discharge with Heart or Kidney Issues
FranceStudy on Re-treatment with Lutetium (177Lu) Vipivotide Tetraxetan for Men with Metastatic Castration-Resistant Prostate Cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on acute myocardial infarction pain management and innovative treatments for severe asthma. Research includes evaluation of novel pain-relief methods and assessment of treatment discontinuation strategies.
Studies also examine beta-blocker discontinuation in patients with recovered heart function.
Extensive research in blood cancers, including multiple myeloma, acute myeloid leukemia, and various lymphomas. Studies evaluate novel drug combinations and treatment strategies.
Investigations include targeted therapies and personalized treatment approaches for various cancer types.
Research focusing on respiratory syncytial virus (RSV) prevention in infants and children. Studies evaluate new protective treatments and their safety profiles.
Trials include assessment of novel medications for preventing severe respiratory infections in vulnerable populations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
